Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

    Receive Latest News

    Share Us

    Oncology Strategy Meeting Boston 2019 | Proventa International

    View: 76

    Website | Edit Freely

    Category Immuno-Oncology, Medical Affairs Oncology, Clinical Pharmacology, Oncology Clinical Biostatistics

    Deadline: November 18, 2019 | Date: November 18, 2019

    Venue/Country: Le Méridien Boston Cambridge, U.S.A

    Updated: 2019-10-04 11:15:28 (GMT+9)

    Call For Papers - CFP

    Proventa International’s unique format of Oncology Strategy Meeting San Francisco 2019 gathers seasoned local and global thought leaders in an exclusive discussion where director-level professionals share knowledge and insights on key strategic challenges. This year's Oncology Strategy Meeting will be held at Le Méridien Boston Cambridge on November 18, 2019. For more information, visit

    Who should attend?

    Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:

    Oncology R&D, Translational Research/Development, Clinical Research/Development, Immuno-Oncology, Medical Affairs Oncology, Clinical Pharmacology, Oncology Clinical Biostatistics, Oncology Clinical Genomics, Computational Biology, Oncology R&D Innovation, Oncology R&D Strategy, Oncology Portfolio Management

    Submit your interest to attend, sponsor or partner!

    Delegate Registration:

    Sponsorship Opportunities:

    Media Partnership:

    To see other strategy meetings near you, please visit

    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.